RTL
KROS icon

Red Tortoise LLC’s Keros Therapeutics KROS Stock Holding History

Red Tortoise LLC’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$618 Hold
56
– – ﹤0.01% 579
2025
Q4 		$1.14K Sell
56
-90
-62% -$1.58K ﹤0.01% 580
2025
Q3 		$2.31K Hold
146
– – ﹤0.01% 514
2025
Q2 		$1.95K Buy
+146
New +$1.97K ﹤0.01% 546

Other funds holding KROS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Red Tortoise LLC's KROS Position: Q1 2026 in Review

Red Tortoise LLC held its Keros Therapeutics (KROS) position steady in Q1 2026 at 56 shares worth $618. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Red Tortoise LLC first reported a position in KROS in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.31K in Q3 2025. 151 funds tracked by Wall St. Rank hold KROS as of Q1 2026.

  • Red Tortoise LLC held 56 shares of Keros Therapeutics worth $618 as of Q1 2026.
  • Red Tortoise LLC left its Keros Therapeutics share count unchanged in Q1 2026.
  • Keros Therapeutics made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #579 holding.
  • Red Tortoise LLC first reported a position in Keros Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Red Tortoise LLC's Keros Therapeutics position peaked at $2.31K in Q3 2025.
  • 151 funds tracked by Wall St. Rank held Keros Therapeutics as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.